WaferGen Biosystems
Biotechnology, Genetics, Life Science, Pharmaceutical
Founded in 2002-01-01
Fremont, California, United States
For Profit
About WaferGen Biosystems
WaferGen Bio-systems, Inc. is an emerging genomic analysis company in the early stage of commercialization. The company offers the transformative SmartChip Real-Time PCR System—a next-generation Real-Time PCR System for profiling and validation of gene expression patterns (biomarkers) on a single platform. The SmartChip System provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling and single nucleotide polymorphism (SNP) genotyping.
Company Metrics
- Employees: 51-100
- Monthly Visits: None
- Tech Stack: 12 active products
Financial Information
- Estimated Revenue: $10M to $50M
- Total Funding: 86896750 USD
- Last Funding: 15000000 USD (Post-IPO Equity)
- Funding Status: M&A
Technology Stack
WaferGen Biosystems actively uses 12 products in their tech stack.
Market Presence
Industries: Biotechnology, Genetics, Life Science, Pharmaceutical
Headquarters: Fremont, California, United States